Business Context and Reporting Period
This Form 8-K is a current report filed by Chavant Capital Acquisition Corp. (the "Registrant") on June 22, 2023. The filing details a material definitive agreement entered into to support the proposed business combination with Mobix Labs, Inc. (the "Proposed Transaction"). The Registrant is a Cayman Islands special purpose acquisition company (SPAC) with securities trading on The Nasdaq Stock Market LLC under the symbols CLAYU, CLAY, and CLAYW.
Key Financial Metrics and Obligations
The filing discloses the creation of a direct financial obligation rather than reporting standard operating financial metrics such as revenue or profit.
- Debt Instrument: Unsecured Promissory Note issued to the Sponsor, Chavant Capital Partners LLC.
- Principal Amount: Up to $500,000.00.
- Interest Rate: 10.0% per annum.
- Maturity Date: Payable in full upon the earlier of (i) consummation of the Proposed Transaction or (ii) one year from issuance (June 22, 2024).
- Use of Proceeds: Funding ongoing working capital requirements and potential deposits into the Trust Account to extend the business combination deadline from July 22, 2023, to January 22, 2024.
- Repayment Source: If the transaction closes, repayment may come from Trust Account proceeds. If the transaction fails, repayment must come from working capital held outside the Trust Account.
Material Changes and Transaction Status
The primary material change is the issuance of the Promissory Note to secure liquidity for the extension of the business combination deadline. The Registrant is seeking shareholder approval to extend the deadline for the merger with Mobix Labs. The filing references a definitive proxy statement filed on the same date regarding this extension and the Proposed Transaction.
Outlook, Risks, and Management Commentary
Management highlights significant risks associated with the Proposed Transaction and the future operations of the combined entity. Key forward-looking risks include:
- Transaction Completion: Risk that the merger may not be completed in a timely manner or at all, including failure to obtain the deadline extension or satisfy minimum cash conditions following redemptions.
- Operational Risks: Mobix Labs may face delays in commercializing semiconductor products, may never achieve profitability, or may require additional capital on unfavorable terms.
- Market and Regulatory Risks: Volatility in security prices, changes in 5G technology, global supply chain disruptions, and U.S./China trade tensions.
- Legal and IP Risks: Potential legal proceedings regarding the Business Combination Agreement and uncertainties regarding patent approvals for Mobix Labs.
- Listing Risks: Inability to maintain Nasdaq listing requirements for the post-combination company.
Investor Verification Checklist
- Verify the status of the shareholder vote on the extension of the business combination deadline (July 22, 2023 to January 22, 2024).
- Review the definitive proxy statement/prospectus (Form S-4) for details on the minimum cash amount required to close the transaction.
- Confirm whether the $500,000 Promissory Note has been fully funded and the specific allocation between working capital and Trust Account deposits.
- Assess Mobix Labs' progress on commercializing semiconductor products and any updates on patent applications.
- Monitor the status of the PIPE investment and whether it has been secured to support the transaction.